Ticker Hub

ADA

ADA company profile

Latest price

——

As of — · Market data by Massive

Market cap

—

Volume

—

Previous close

—

Day range

—

Listed

—

Coverage

4 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
Intraday chart history is not available yet.

Newsroom

Latest ADA coverage

On the Brink: Small Business Owners Can't Afford ADA Website Lawsuits
NewsApr 7, 2023

On the Brink: Small Business Owners Can't Afford ADA Website Lawsuits

[ad_1] Arlington, TX – (NewMediaWire) – April 7, 2023 – Small business owners across the United States are facing numerous challenges that threaten their survival, including a persistent problem that has received less coverage in mainstream media: ADA website litigation. This is especially true for small business owners in states like Calif

ADATXDOJ
ADA Compliance Course Helps Website Owners Avoid Lawsuits and Improve Accessibility
NewsMar 11, 2023

ADA Compliance Course Helps Website Owners Avoid Lawsuits and Improve Accessibility

[ad_1] Arlington, TX – (NewMediaWire) – March 10, 2023 – An attorney who specializes in ADA compliance for websites has created a course that helps website owners prevent litigation through genuine accessibility. Kris Rivenburgh, the course creator and author of The ADA Book, knows his course is the best answer. “The ADA Compliance Course t

ADATX
SCD
NewsDec 15, 2021

Survey: Holidays place extra stress on people managing type 2 diabetes

[ad_1] (NewMediaWire) – December 14, 2021 – ARLINGTON, Va. and DALLAS – Nearly half (49%) of people living with type 2 diabetes said managing their condition during a typical fall and winter holiday season is more difficult than other times of the year, according to a new survey for the American Heart Association and American Diabetes ...

COVIDFAHAAHAADA
Orchard Therapeutics commits to gene therapies production facility with plans to hire 100 workers
PharmaDec 13, 2018

Orchard Therapeutics commits to gene therapies production facility with plans to hire 100 workers

[ad_1] Orchard Therapeutics mentioned it supposed to use a few of the proceeds of an IPO to construct a producing facility for its gene therapies program and now it's. With about $225 million in hand from the IPO, the biotech will spend a lot of that on a plant in California. The transatlantic biotech announced on Thursday ...

EUADASCID
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.